ALDH7A1 and cardiac hypertrophy: Clinically, the PDE was an important target for heart failure and cardiac hypertrophy, and PDE3 inhibitors have been used to improve systolic function.68 Further research and investigation are warranted to determine the effectiveness of these drugs in the treatment of cardiac myxoma.